AlphAIalphai — Financial news for AI agents
insidermonkey.comJUN 14 min read$ACHC

Buckley Capital’s Insights on Acadia Healthcare (ACHC)

Buckley Capital Advisors’ Q1 2026 investor letter said small- and mid-cap equities were difficult in the quarter, but its portfolio rose about 13.8% net month-to-date in April and 8.6% net year-to-date, with gains continuing into May. The firm cited Acadia Healthcare (NASDAQ: ACHC), which closed at $23.20 on May 29, 2026. Buckley said it trimmed ACHC after it became its largest 2026 contributor and noted CEO Debra “Debbie” Osteen’s reappointment.

Original reporting
insidermonkey.com
Published Jun 1, 2026, 3:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 1, 2026, 4:29 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Buckley Capital’s Insights on Acadia Healthcare (ACHC) — source image
Source · insidermonkey.com
Decision brief

The 30-second read

$ACHCBullishLow
01

Why it matters

The only company-specific element is ACHC being framed as a “special situation” due to CEO reappointment and its contribution to performance; the article does not disclose new financial results or guidance.

02

Market read

Primarily positioning/sentiment read-through; limited direct trading edge without new ACHC fundamentals or a discrete event date.

03

What to watch

Investor-letter commentary may lag real catalysts; traders should prioritize upcoming ACHC earnings, guidance, and any regulatory/reimbursement updates over this narrative.

Relevance 6/10Novelty 2/10Timing: today’s read-through of Q1 investor-letter positioning (no new ACHC filing/print)

Background

Buckley Capital published its Q1 2026 investor letter, highlighting performance in April/May and discussing top holdings, including Acadia Healthcare.

Company-level read

Ticker impact

$ACHCBullishMedium confidence
Context

Buckley Capital’s Q1 2026 letter names Acadia Healthcare as its largest contributor and says it is trimming at current prices after CEO reappointment.

Expected impact

Near-term sentiment may be mildly supportive, but it’s not a new fundamental catalyst; expect limited follow-through versus earnings/regulatory events.

Evidence & confidence

The article provides no new company-specific operational/financial datapoints beyond investor-letter commentary and a CEO reappointment reference; it mainly informs positioning and narrative rather than fundamentals.

Market effects

Sector

Behavioral health operators may see sentiment lift when a proven operator returns, but this is not a sector-wide new data point.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Trimming after a run can signal reduced near-term upside conviction rather than fresh bullish fundamentals.

Key entities

  • public_company
    Acadia Healthcare Company, Inc.

    Behavioral health services provider; discussed as Buckley’s largest contributor and a position being trimmed at current prices.

  • person
    Debra “Debbie” Osteen

    Reappointed CEO of Acadia Healthcare; cited as the catalyst for the investment thesis.

  • investment_firm
    Buckley Capital Advisors

    Published the Q1 2026 investor letter containing the ACHC commentary.

Read at source← All news

Related articles

JUL 30
$ACHCMedAI 8/10

Acadia Healthcare Q2 Earnings Call Highlights

Acute care: Revenue was $495 million, flat year over year but up 6% after normalizing for supplemental payments. Management cited strong volumes and admissions at existing acute facilities as well as newer joint-venture and de novo locations. Specialty care: Revenue was $134 million, up 4% sequentially from the first quarter. The business experienced the full-quarter impact of the New York Medicaid decision.

yahoo.com6 min
JUL 28
$ACHCMedAI 8/10

Acadia Healthcare: Q2 Earnings Snapshot

Acadia Healthcare Co. (ACHC) reported Q2 net income of 12 cents per share and adjusted earnings of 38 cents per share, versus a Zacks mean estimate of 33 cents. Revenue was $865.8 million, above the $844.7 million forecast. Full-year guidance calls for EPS of $1.45 to $1.60 and revenue of $3.4 billion to $3.45 billion.

local3news.com2 min
JUL 28
$ACHCMed

Acadia Healthcare (NASDAQ:ACHC) Posts Better

Acadia Healthcare (NASDAQ:ACHC) reported Q2 CY2026 revenue of $865.8 million, flat year on year but above expectations by about 2%, and non-GAAP adjusted EPS of $0.38, down from $0.83 but 9.7% above consensus. The company guided full-year revenue to about $3.43 billion. Shares fell about 1.3% to $32.18 after the report.

financialcontent.com6 min
JUL 28
$ACHCMed

Acadia Healthcare Company, Inc. (ACHC): Results of Operations and Financial Condition

Acadia Healthcare Company, Inc. (ACHC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_994474.htm EXHIBIT 99.1 ex_994474.htm Exhibit 99.1 ACADIA HEALTHCARE ANNOUNCES SECOND QUARTER 2026 RESULTS AND UPDATES FULL YEAR 2026 FINANCIAL AND CASH FLOW GUIDANCE FRANKLIN, Tenn. (July 28, 2026 ) – Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASD

SEC EDGAR 8-K4 min